SCHEMBL16420342

SCHEMBL16420342

Cc1c(N2c3cc4ccccc4cc3N(C)[C@H]2C)cccc1N1c2cc3ccccc3cc2N(C)[C@@H]1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.49
▸ ALDH1A1 P00352 5/20 0.49
▸ GAA P10253 4/20 0.49
▸ HPGD P15428 4/20 0.49
▸ ALOX12 P18054 1/20 0.49
▸ GPR3 P46089 1/20 0.32
▸ MYC P01106 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 3/20 0.31
▸ CYP2A6 P11509 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ HTT P42858 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ NSD2 O96028 2/20 0.30
▸ PDGFRB P09619 1/20 0.30
▸ PTPN2 P17706 1/20 0.30
▸ PTPN1 P18031 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16420349 0.90 KDM4E (0.41) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16420353 0.89 KDM4E (0.40) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL17655191 0.87 KDM4E (0.44) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16709150 0.87 KDM4E (0.44) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16420322 0.84 KDM4E (0.47) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16420352 0.81 ALDH1A1 (0.70) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16420358 0.80 ALDH1A1 (0.42) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL16420350 0.80 ALDH1A1 (0.39) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL13847595 0.80 KDM4E (0.44) KDM4EALDH1A1GAAHPGDALOX12
SCHEMBL12392991 0.80 KDM4E (0.44) KDM4EALDH1A1GAAHPGDALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170250354-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-08-31 — — US disclosed
US-20170250354-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-08-31 — — US disclosed
US-20150028290-A1 HETEROLEPTIC OSMIUM COMPLEX AND METHOD OF MAKING THE SAME UNIVERSAL DISPLAY CORPORATION (US) 2015-01-29 — — US disclosed
US-20150028290-A1 HETEROLEPTIC OSMIUM COMPLEX AND METHOD OF MAKING THE SAME UNIVERSAL DISPLAY CORPORATION (US) 2015-01-29 — — US disclosed
EP-2830109-A1 Heteroleptic osmium complex and method of making the same Universal Display Corporation (US) 2015-01-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250354-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBPL3, OR10J3, OSBP2 KDM4E 3560/4885ALDH1A1 1215/4885GAA 4541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback